Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 18, 2011, Pages 7499-7504

  Adams, William C ^a,b   Gujer, Cornelia ^a   McInerney, Gerald ^a   Gall, Jason G D ^c   Petrovas, Constantinos ^b   Karlsson Hedestam, Gunilla B ^a   Koup, Richard A ^b   Loré, Karin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MEMBRANE COFACTOR PROTEIN; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADENOVIRIDAE; ANTIGENS, CD46; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, VIRUS;

ADENOVIRIDAE;

EID: 79956330963     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017146108     Document Type: Article

References (41)

1. Barouch DH, Nabel GJ (2005) Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther 16:149-156. (Pubitemid 40344207)
2. Barouch DH, et al. (2004) Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol 172:6290-6297. (Pubitemid 38621236)
3. Bergelson JM, et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323. (Pubitemid 27114163)
4. Adams WC, et al. (2009) Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. J Gen Virol 90:1600-1610.
5. Johansson C, et al. (2007) Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J Virol 81:954-963. (Pubitemid 46067920)
6. Kalyuzhniy O, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 105:5483-5488. (Pubitemid 351753889)
7. Waddington SN, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409. (Pubitemid 351200513)
8. Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med 9:1408-1412. (Pubitemid 37466191)
9. Arnberg N (2009) Adenovirus receptors: Implications for tropism, treatment and targeting. Rev Med Virol 19:165-178.
10. Loré K, et al. (2007) Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses. J Immunol 179:1721-1729.
11. Oglesby TJ, Allen CJ, Liszewski MK, White DJ, Atkinson JP (1992) Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 175:1547-1551.
12. Cattaneo R (2004) Four viruses, two bacteria, and one receptor: Membrane cofactor protein (CD46) as pathogens' magnet. J Virol 78:4385-4388.
13. Bartz R, et al. (1996) Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology 224:334-337. (Pubitemid 26358132)
14. Schnorr JJ, et al. (1995) Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur J Immunol 25:976-984.
15. Santoro F, et al. (1999) CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827. (Pubitemid 30017651)
16. Gill DB, Koomey M, Cannon JG, Atkinson JP (2003) Down-regulation of CD46 by piliated Neisseria gonorrhoeae. J Exp Med 198:1313-1322. (Pubitemid 37392477)
17. Okada N, Liszewski MK, Atkinson JP, Caparon M (1995) Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci USA 92:2489-2493.
18. Wang G, Liszewski MK, Chan AC, Atkinson JP (2000) Membrane cofactor protein (MCP; CD46): Isoform-specific tyrosine phosphorylation. J Immunol 164:1839-1846. (Pubitemid 30108737)
19. Cardone J, et al. (2010) Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol 11:862-871.
20. Kemper C, Atkinson JP (2007) T-cell regulation: With complements from innate immunity. Nat Rev Immunol 7:9-18. (Pubitemid 46020823)
21. Marie JC, et al. (2002) Linking innate and acquired immunity: Divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 3:659-666. (Pubitemid 34752475)
22. Wang H, et al. (2007) Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob. J Virol 81:12785-12792. (Pubitemid 350156916)
23. Buchholz CJ, et al. (1997) Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 272:22072-22079. (Pubitemid 27382833)
24. Fleischli C, et al. (2005) The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35. J Virol 79:10013-10022. (Pubitemid 41022342)
25. Nanda A, et al. (2005) Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. J Virol 79:14161-14168. (Pubitemid 41552714)
26. Meiffren G, Flacher M, Azocar O, Rabourdin-Combe C, Faure M (2006) Cutting edge: Abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathway. J Immunol 177:4957-4961. (Pubitemid 44527563)
27. Oliaro J, et al. (2006) Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. Proc Natl Acad Sci USA 103:18685-18690. (Pubitemid 44913471)
28. Ophorst OJ, et al. (2004) An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine 22:3035-3044. (Pubitemid 39037205)
29. Shiver JW, Emini EA (2004) Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 55:355-372. (Pubitemid 38316732)
30. Joubert PE, et al. (2009) Autophagy induction by the pathogen receptor CD46. Cell Host Microbe 6:354-366.
31. Karp CL, et al. (1996) Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228-231. (Pubitemid 26285887)
32. Nemerow GR, Pache L, Reddy V, Stewart PL (2009) Insights into adenovirus host cell interactions from structural studies. Virology 384:380-388.
33. Pache L, Venkataraman S, Nemerow GR, Reddy VS (2008) Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses. Virology 375:573-579.
34. Kemper C, et al. (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388-392. (Pubitemid 36157938)
35. Lövkvist L, et al. (2008) CD46 Contributes to the severity of group A streptococcal infection. Infect Immun 76:3951-3958.
36. Sakurai F, Akitomo K, Kawabata K, Hayakawa T, Mizuguchi H (2007) Downregulation of human CD46 by adenovirus serotype 35 vectors. Gene Ther 14:912-919. (Pubitemid 46780074)
37. Crimeen-Irwin B, et al. (2003) Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J Biol Chem 278:46927-46937.
38. Yant S, Hirano A, Wong TC (1997) Identification of a cytoplasmic Tyr-X-X-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection. J Virol 71:766-770. (Pubitemid 26412356)
39. Persson BD, et al. (2010) Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog 6:e1001122.
40. Douagi I, et al. (2009) Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells. J Immunol 182:1991-2001.
41. Cheng C, et al. (2007) Mechanism of ad5 vaccine immunity and toxicity: Fiber shaft targeting of dendritic cells. PLoS Pathog 3:e25.